Cargando…
Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells
RRM1—an important DNA replication/repair enzyme—is the primary molecular gemcitabine (GEM) target. High RRM1-expression associates with gemcitabine-resistance in various cancers and RRM1 inhibition may provide novel cancer treatment approaches. Our study elucidates how RRM1 inhibition affects cancer...
Autores principales: | Zhang, Xia, Taoka, Rikiya, Liu, Dage, Matsuoka, Yuki, Tohi, Yoichiro, Kakehi, Yoshiyuki, Sugimoto, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071414/ https://www.ncbi.nlm.nih.gov/pubmed/33921102 http://dx.doi.org/10.3390/ijms22084102 |
Ejemplares similares
-
Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer
por: Tohi, Yoichiro, et al.
Publicado: (2022) -
Efficacy and toxicity of intravesical Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer
por: Matsuoka, Yuki, et al.
Publicado: (2021) -
Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012) -
A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
por: Oehmig, Angelika, et al.
Publicado: (2008) -
Criteria for effective design, construction, and gene knockdown by shRNA vectors
por: Taxman, Debra J, et al.
Publicado: (2006)